Saxenda® (liraglutide) injection 3 mg is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in:

• Adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
• Pediatric patients aged 12 years and older with body weight above 60 kg (132 lbs) and initial BMI corresponding to 30 kg/m2 or more excellent for adults (obese) by international cut-offs

What is Saxenda® (liraglutide) injection 3 mg?

Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (Body Mass Index ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxenda® should be used with a reduced-calorie diet and increased physical activity.

• Saxenda® and Victoza® have the same active ingredient, liraglutide, and should not be used with other GLP-1 receptor agonist medicines.
• It is unknown if Saxenda® is safe and effective when taken with other prescription, over-the-counter medicines, or herbal weight-loss products.
• It is not known if Saxenda® is safe and effective in children under 12 years of age.
• It is unknown if Saxenda® is safe and effective in children aged 12 to 17 with type 2 diabetes.

What is the most important information I should know about Saxenda®?

• Serious side effects may happen in people who take Saxenda®, including:
  • Possible thyroid tumors, including cancer. Tell your healthcare professional if you have a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Saxenda® and medicines that work like Saxenda® caused thyroid tumors, including thyroid cancer. It is unknown if Saxenda® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
  • Do not use Saxenda® if you or any of your family have ever had MTC or have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

How should I use Saxenda®?

• Inject your dose of Saxenda® under the skin (subcutaneously) in your stomach area (abdomen), upper leg (thigh), or upper arm, as instructed by your health care provider. Do not inject into a vein or muscle.